YSB

YSB AAQS

The The AAQS of YSB (9885.HK) as of Oct 21, 2026 is 2. In the previous year, The AAQS was 2.00 — a change of 0.00% (lower).

AAQS

2

YoY

0.00%

Last updated:

YSB has a current AAQS of 2.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock YSB in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The YSB AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2020
2.00 CNY
Jan 1, 2021
2.00 CNY
Jan 1, 2022
2.00 CNY
Jan 1, 2023
2.00 CNY
Jan 1, 2024
2.00 CNY
Jan 1, 2025
2.00 CNY
The YSB AAQS history
YEARAAQSYoY
20.00%
20.00%
20.00%
20.00%
20.00%
2—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

YSB Stock analysis

What does YSB do? YSB, Inc. generates revenue through the wholesale and retail of pharmaceuticals and healthcare products via offline and online platforms. The company operates an online platform enabling pharmaceutical distributors to sell their products, while also offering software-as-a-service (SaaS) solutions to pharmacies. Additionally, YSB sells smart unmanned pharmaceutical booths to third-party pharmacies and provides maintenance and technical support services for these booths. The firm's primary market is domestic, serving pharmacies, distributors, and primary medical institutions through its SaaS and testing services. The company's SaaS solutions target pharmacies, helping them manage operations, while the smart unmanned pharmaceutical booths are sold to third-party pharmacies for retail distribution. Medical testing services are provided directly to primary medical institutions, and the firm's online platform connects distributors with buyers. All services and products are focused on the domestic market, with no international operations mentioned in the description. YSB, Inc. makes money by selling pharmaceuticals and healthcare products through its platforms, offering SaaS to pharmacies, and providing maintenance services for smart booths. The firm's revenue streams include direct sales of products, SaaS subscriptions, booth sales, and technical support contracts. Primary customers are pharmacies, distributors, and primary medical institutions, all operating within China's domestic market. YSB is one of the most popular companies on Eulerpool.

Frequently Asked Questions about YSB stock

The AAQS of YSB is 2 in 2025.

On Eulerpool you can find the complete historical development of The AAQS YSB since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — YSB

All Key Metrics — YSB